Deviney Marie Chaponis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dacarbazine | 1 | 2011 | 567 | 0.310 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2011 | 627 | 0.290 |
Why?
|
| Piperidines | 1 | 2011 | 1605 | 0.210 |
Why?
|
| Pyridines | 1 | 2011 | 2822 | 0.170 |
Why?
|
| Self-Help Groups | 1 | 2017 | 190 | 0.140 |
Why?
|
| Glioma | 1 | 2011 | 3401 | 0.130 |
Why?
|
| Appointments and Schedules | 1 | 2017 | 417 | 0.120 |
Why?
|
| Prenylation | 1 | 2011 | 37 | 0.100 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 258 | 0.090 |
Why?
|
| Eicosanoids | 1 | 2011 | 279 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8860 | 0.090 |
Why?
|
| Fish Oils | 1 | 2011 | 470 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2008 | 88 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2085 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2011 | 1791 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2008 | 196 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 1275 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 1060 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10480 | 0.070 |
Why?
|
| Pyrroles | 1 | 2011 | 1143 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2011 | 1226 | 0.060 |
Why?
|
| Superior Colliculi | 1 | 2004 | 99 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2004 | 167 | 0.060 |
Why?
|
| Indoles | 1 | 2011 | 1838 | 0.060 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2011 | 1344 | 0.050 |
Why?
|
| Orientation | 1 | 2004 | 327 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 10949 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2038 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4841 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2017 | 4556 | 0.050 |
Why?
|
| Cues | 1 | 2005 | 873 | 0.050 |
Why?
|
| Space Perception | 1 | 2004 | 475 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 16687 | 0.040 |
Why?
|
| Auditory Perception | 1 | 2004 | 569 | 0.040 |
Why?
|
| Memory | 1 | 2005 | 2174 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 1901 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5529 | 0.030 |
Why?
|
| Diet | 1 | 2011 | 7937 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 1321 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 40063 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18027 | 0.030 |
Why?
|
| Mice | 4 | 2011 | 81178 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 2011 | 136 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 257 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2011 | 434 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 419 | 0.020 |
Why?
|
| Animals | 6 | 2011 | 168788 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 2682 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23404 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 544 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 2716 | 0.020 |
Why?
|
| Columbidae | 1 | 2005 | 40 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1914 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 599 | 0.020 |
Why?
|
| Endothelium | 1 | 2008 | 778 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2011 | 14556 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3557 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1888 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2004 | 237 | 0.010 |
Why?
|
| Denervation | 1 | 2004 | 278 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 2065 | 0.010 |
Why?
|
| Cats | 1 | 2004 | 998 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6612 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 21824 | 0.010 |
Why?
|
| Auditory Pathways | 1 | 2004 | 233 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2636 | 0.010 |
Why?
|
| Ligands | 1 | 2008 | 3294 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3506 | 0.010 |
Why?
|
| Cornea | 1 | 2008 | 1524 | 0.010 |
Why?
|
| Visual Pathways | 1 | 2004 | 565 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4455 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1080 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 21672 | 0.010 |
Why?
|
| Mitochondria | 1 | 2011 | 3520 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 1881 | 0.010 |
Why?
|
| Humans | 5 | 2017 | 744220 | 0.010 |
Why?
|
| Visual Fields | 1 | 2004 | 1049 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3478 | 0.010 |
Why?
|
| Male | 3 | 2017 | 350027 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5709 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9335 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 213367 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 214035 | 0.000 |
Why?
|
| Female | 1 | 2017 | 380197 | 0.000 |
Why?
|